We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Antidepressant Based on Ketamine Gets Backing From FDA Advisory Group

News   Feb 13, 2019 | Original story by Sara Reardon for Nature

 
Antidepressant Based on Ketamine Gets Backing From FDA Advisory Group

Credit: Pixabay

 
 
 

RELATED ARTICLES

Lung Therapy Targets Derived From Fetal Signaling Pathways

News

Specialized lung cells appear in the developing fetus much earlier than scientists previously thought.

READ MORE

3D Protein Structure Aids Anti-cancer Drug Design

News

A research team has discovered a new mechanism for a class of anti-cancer drugs known as E1 inhibitors. Their findings reveal a novel binding site that will promote drug design of more efficient E1 inhibitors.

READ MORE

Sparing Sensitive Organs from Radiation Damage to Reduce Side Effects

News

A new way to plan radiotherapy could help shape treatment away from sensitive organs near tumors to reduce side-effects, a new study shows.

READ MORE

 

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE